Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials
Year: 2023
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: International Journal of Obesity
Institutions: Universidade Federal do Rio de Janeiro, Immanuel Kant Baltic Federal University, Universitat Internacional de Catalunya, Harvard University, Massachusetts General Hospital, Universidade Federal de Minas Gerais, Universidade Federal do Rio Grande do Norte, Brigham and Women's Hospital, Thrombolysis in Myocardial Infarction Study Group
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4384521950
